Thermalin’s lead product is a highly concentrated, rapid acting insulin with the potential to dramatically change the lives of millions of people with type II and type I diabetes across the globe. The Thermalin Team includes players who have significantly influenced the world of insulin for over 30 years. Founder Michael Weiss has published over 150 peer reviewed articles (more than half on insulin) and VP of Development Bruce Frank is a co-inventor of Humalog, the first ever fast acting insulin. Thermalin will initiate its phase Ia clinical study and is uniquely positioned to reach a major value inflection point at a time when there will be a high demand for new insulin products.
Location: United States, Ohio, Columbus
Employees: 11-50
Total raised: $13.3M
Founded date: 2009
Investors 5
| Date | Name | Website |
| - | Mass Medic... | massmedang... |
| 09.07.2021 | Robin Hood... | robinhoodv... |
| - | Mid Atlant... | bioangels.... |
| - | Kensington... | kensington... |
| - | Innovation... | innovation... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 28.07.2014 | Series B | $5.9M | - |
| 25.04.2012 | Grant | $4.5M | - |
| 28.03.2011 | Series A | $2.9M | - |
Mentions in press and media 22
| Date | Title | Description |
| 31.07.2014 | Thermalin Diabetes Raises $5.9M in Series B | CLEVELAND, OH, Thermalin Diabetes has raised $5.9 million from private investors in the first tranche of a Series B round. >> Click here for more funding data on Thermalin Diabetes >> To export Thermalin Diabetes funding dat... |
| 28.07.2014 | New-wave insulin maker Thermalin Diabetes raises $5.9M | The funding will also support large-animal studies for Thermalin-biphasic, a next-gen replacement for pre-mix insulins. The substance doesn’t require refrigeration, and is geared toward the China and India markets. Lastly, the company is in... |
| 30.04.2014 | Today on the Hangout: Funding for biotech, device, pharma startups | Our April hangout features three people who specialize in funding healthcare startups. If you need fresh ideas about where to get financial support for your company, tune in to our hangout at noon Eastern on Wednesday. We will speak with pe... |
| 29.04.2014 | MedCity News Hangout: Where to find funding if you’re not a digital health startup | The panel includes: Richard Berenson, CEO of Thermalin Diabetes and executive committee member of Mass Medical Angels David R. Carter, Principal of Capital Royalty Dorit Donoviel, Ph.D. Deputy Chief Scientist at the National Space Biomedica... |
| 23.04.2014 | Insulin startup Thermalin gets JDRF support for an ultra rapid-acting insulin for T1D | Thermalin’s goal with this project is to manipulate how insulin binds with receptors so that it kicks in quicker and lasts for a shorter period of time. That could potentially curb the need for people with diabetes to snack to avoid a blood... |
| 25.04.2012 | Thermalin Diabetes gets $4.5M NIH grant for next-generation insulin | “We are very excited about this grant because, in addition to providing vital, nondilutive support for our efforts, it represents significant, peer-reviewed validation for our science,” Berenson said. The company’s portfolio of insulin anal... |
| 28.09.2011 | Thermalin Diabetes targets $8M series B investment, eyes clinical trials | Thermalin is targeting the end of 2012 to file an Investigational New Drug (IND) application with the U.S. Food and Drug Administration, which would likely enable the company to begin clinical trials in early 2013, Berenson said. The compan... |
| 29.03.2011 | Thermalin Diabetes snaps up $2.9 million in A round | Funding roundup | Startup Thermalin Diabetes LLC closed a $2.85 million Series A investment round. The Cleveland-based synthetic insulin developer plans to use the funding to step up production of its insulin analogs — new proteins engineered to act like ins... |
| 28.03.2011 | Thermalin Diabetes closes $2.85M Series A investment round | Thermalin has been slowly adding to its Series A round over the last year or so. In October, the round stood at $1.9 million, for example. Investors include various angels and Cleveland economic development and venture group JumpStart, whic... |
| 19.01.2011 | Thermalin aims for better diabetes care without insulin side effects | Weiss is the scientific mind behind Thermalin, and Berenson was brought on to develop the business. So far, the company has raised more than $3 million to support its efforts to develop and commercialize the analogs. Berenson is hoping to c... |
Show more